ERBB2 and gastric cancer: For example, the overexpression status of HER2 (human epidermal growth factor receptor 2) is an important predictor in the treatment of gastric cancer, and detecting the expression level of HER2 protein by IHC can guide clinicians in deciding whether or not to use targeted therapy against HER2 [20].